Related Experiment Video
Updated: Aug 1, 2025

07:11
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
6.4K
Private equity in ophthalmology and optometry: a time series analysis from 2012 to 2021
Sachi A Patil1, Daniel G Vail2, Jacob T Cox3
1Department of Ophthalmology, New York University, Grossman School of Medicine, New York, New York.
Digital Journal of Ophthalmology : DJO
|April 27, 2023
Summary
Private equity acquisitions of ophthalmology and optometry practices surged from 2012 to 2021. This trend highlights a growing interest in regional strategies for consolidating eye care providers.
Area of Science:
- Ophthalmology
- Optometry
- Health Economics
- Business Strategy
Background:
- The healthcare industry, particularly ophthalmology and optometry practices, has seen increasing interest from private equity firms.
- Understanding the trends and patterns of these acquisitions is crucial for stakeholders in the eye care sector.
Purpose of the Study:
- To identify temporal and geographic trends in private equity (PE)-backed acquisitions of ophthalmology and optometry practices in the United States.
- To analyze acquisition data from 2012 to 2021, examining practice types, locations, and provider details.
Main Methods:
- A cross-sectional time series analysis was conducted using acquisition data from 2012 to 2021.
- Data were compiled from financial databases, industry news, and press releases.
- Linear regression models were employed to assess acquisition rates and trends.
Main Results:
- From 2012 to 2021, monthly PE acquisitions increased significantly, by 0.947 per year (P < 0.001).
- Texas, Florida, Michigan, and New Jersey were top states for PE acquisitions.
- Acquisitions continued to rise, particularly in 2021, indicating sustained PE interest.
Conclusions:
- Private equity acquisitions in ophthalmology and optometry have shown a consistent upward trend from 2012 to 2021.
- Companies are increasingly employing regionally focused strategies for practice acquisitions.
- The findings suggest a dynamic market with ongoing consolidation within the eye care sector.
Related Concept Videos
Open Angle Glaucoma: Treatment
504
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
504
Angle Closure Glaucoma: Treatment
587
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
587
Glaucoma: Overview
648
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
648

